<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02051114</url>
  </required_header>
  <id_info>
    <org_study_id>DOR-0833</org_study_id>
    <nct_id>NCT02051114</nct_id>
  </id_info>
  <brief_title>Discovering the Antecedents of Rheumatoid Arthritis Flare</brief_title>
  <official_title>Discovering the Antecedents of Rheumatoid Arthritis Flare</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rockefeller University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rockefeller University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Longitudinal study of patients with rheumatoid arthritis comparing measures of disease&#xD;
      activity with blood samples.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      80% of patients living with rheumatoid arthritis can expect fluctuations in their symptoms&#xD;
      over time. Dramatic increases in disease activity are considered flare. This study will&#xD;
      follow patients with increased risk for flare prospectively for one year. Serial&#xD;
      questionnaires and disease activity scores will be compared to blood samples to better&#xD;
      understand the molecular phenotype of rheumatoid arthritis flares.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">February 2025</completion_date>
  <primary_completion_date type="Anticipated">February 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>RNA transcripts that correlate with rheumatoid arthritis disease activity</measure>
    <time_frame>1 year</time_frame>
    <description>Blood drawn at various times throughout one year will be correlated with fluctuations in RA disease activity.</description>
  </primary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Rheumatoid Arthritis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  2010 criteria for Rheumatoid Arthritis&#xD;
&#xD;
          -  Swelling of at least one joint and or elevated acute phase reactants&#xD;
&#xD;
          -  Greater than or equal to 40 years old or less than or equal to 65 year old female sex&#xD;
&#xD;
          -  cyclic citrullinated peptide antibody + in the past 12 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  hemoglobin &lt; 9&#xD;
&#xD;
          -  white blood cell count &lt; 3.5&#xD;
&#xD;
          -  Diagnosis of any active malignancy within the last 3 years besides non-melanomatous&#xD;
             skin cancer&#xD;
&#xD;
          -  Diagnosis of diabetes and requires insulin&#xD;
&#xD;
          -  HIV+, Hep B S Ag+, Hep C polymerase chain reaction +&#xD;
&#xD;
          -  Untreated latent tuberculosis&#xD;
&#xD;
          -  Diagnosis of any additional systemic autoimmune connective tissue disease&#xD;
&#xD;
          -  Inability to reliably complete study requirements&#xD;
&#xD;
          -  History, physical, social or laboratory findings suggestive of any other medical or&#xD;
             psychological condition that would, in the opinion of the principal investigator, make&#xD;
             the candidate ineligible for the study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dana E Orange, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Rockefeller University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Rockefeller University Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Orange DE, Yao V, Sawicka K, Fak J, Frank MO, Parveen S, Blachere NE, Hale C, Zhang F, Raychaudhuri S, Troyanskaya OG, Darnell RB. RNA Identification of PRIME Cells Predicting Rheumatoid Arthritis Flares. N Engl J Med. 2020 Jul 16;383(3):218-228. doi: 10.1056/NEJMoa2004114.</citation>
    <PMID>32668112</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 29, 2014</study_first_submitted>
  <study_first_submitted_qc>January 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2014</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rheumatoid arthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

